Two abstracts accepted for presentation One abstract on new additional biomarker and immunogenicity data for personalized cancer vaccine EVX-01 Another abstract on the use of Evaxion’s AI-Immunology™ ...
TACTI-004 planned ~756 patients across >150 sites and enrolled 378 by February 2026, including squamous and nonsquamous NSCLC irrespective of PD-L1 status. Randomization compared eftilagimod alfa plus ...
Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best Safe Dividend Stocks for 2026. On March 12, Wells Fargo raised its ...
Stocktwits on MSN
IBRX stock rises overnight: Retail bets Anktiva’s NCCN 'recommended' tag will drive prescriptions and insurance wins
Stocktwits activity surged after the NCCN update, with message volumes jumping over 300% in 24 hours. ・Retail traders flagged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results